These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37772700)

  • 1. A new, all-encompassing aetiology of type 1 diabetes.
    de Groen PC
    Immunology; 2024 Jan; 171(1):77-91. PubMed ID: 37772700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
    Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
    BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.
    Wägner AM; Santana A; Herńndez M; Wiebe JC; Nóvoa J; Mauricio D;
    Diabetes Metab Res Rev; 2011 Jul; 27(5):493-8. PubMed ID: 21744463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.
    Nakayama M; McDaniel K; Fitzgerald-Miller L; Kiekhaefer C; Snell-Bergeon JK; Davidson HW; Rewers M; Yu L; Gottlieb P; Kappler JW; Michels A
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4429-34. PubMed ID: 25831495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.
    Miyadera H; Tokunaga K
    J Hum Genet; 2015 Nov; 60(11):697-702. PubMed ID: 26290149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).
    Wagner DH
    Clin Exp Immunol; 2016 Sep; 185(3):271-80. PubMed ID: 27271348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
    Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
    J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes.
    Yang J; Chow IT; Sosinowski T; Torres-Chinn N; Greenbaum CJ; James EA; Kappler JW; Davidson HW; Kwok WW
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14840-5. PubMed ID: 25267644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide.
    Wiles TA; Hohenstein A; Landry LG; Dang M; Powell R; Guyer P; James EA; Nakayama M; Haskins K; Delong T; Baker RL
    Front Immunol; 2021; 12():668680. PubMed ID: 34113344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.
    Busch R; De Riva A; Hadjinicolaou AV; Jiang W; Hou T; Mellins ED
    Expert Rev Mol Med; 2012 Jul; 14():e15. PubMed ID: 22805744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes.
    Bronson PG; Ramsay PP; Thomson G; Barcellos LF;
    Diabetes Obes Metab; 2009 Feb; 11 Suppl 1(Suppl 1):74-83. PubMed ID: 19143818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
    Ge X; James EA; Reijonen H; Kwok WW
    J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.
    Miyadera H; Ohashi J; Lernmark Å; Kitamura T; Tokunaga K
    J Clin Invest; 2015 Jan; 125(1):275-91. PubMed ID: 25485681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex.
    Kosmopoulou A; Vlassi M; Stavrakoudis A; Sakarellos C; Sakarellos-Daitsiotis M
    J Comput Chem; 2006 Jul; 27(9):1033-44. PubMed ID: 16639700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes.
    Golden B; Levin L; Ban Y; Concepcion E; Greenberg DA; Tomer Y
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4904-11. PubMed ID: 15928253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
    Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
    Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.
    Pathiraja V; Kuehlich JP; Campbell PD; Krishnamurthy B; Loudovaris T; Coates PT; Brodnicki TC; O'Connell PJ; Kedzierska K; Rodda C; Bergman P; Hill E; Purcell AW; Dudek NL; Thomas HE; Kay TW; Mannering SI
    Diabetes; 2015 Jan; 64(1):172-82. PubMed ID: 25157096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes.
    Wang Y; Sosinowski T; Novikov A; Crawford F; Neau DB; Yang J; Kwok WW; Marrack P; Kappler JW; Dai S
    Proc Natl Acad Sci U S A; 2018 Jan; 115(1):162-167. PubMed ID: 29255035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.
    Lombardi A; Concepcion E; Hou H; Arib H; Mezei M; Osman R; Tomer Y
    J Autoimmun; 2020 Dec; 115():102543. PubMed ID: 32951964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.